NDC 73070-200
Insulin Aspart Protamine and Insulin Aspart
Insulin Aspart
Insulin Aspart Protamine and Insulin Aspart is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk Pharma, Inc.. The primary component is Insulin Aspart.
| Product ID | 73070-200_1c04ffb3-6977-4e04-a16f-8e3f6033fa37 |
| NDC | 73070-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Insulin Aspart Protamine and Insulin Aspart |
| Generic Name | Insulin Aspart |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2001-11-01 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA021172 |
| Labeler Name | Novo Nordisk Pharma, Inc. |
| Substance Name | INSULIN ASPART |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [CS],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |